Tema Oncology ETF (CANC) Institutional Ownership $26.90 +0.38 (+1.43%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Tema Oncology ETF (NASDAQ:CANC)Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$10.89MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$2.81M Get CANC Insider Trade Alerts Want to know when executives and insiders are buying or selling Tema Oncology ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Tema Oncology ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/15/2024 Jane Street Group LLC44,311$1.26M0.0%-69.1%2.547% 11/7/2024 Thrivent Financial for Lutherans399,509$11.35M0.0%+25.1%22.960% 8/13/2024 Thrivent Financial for Lutherans319,376$8.62M0.0%N/A19.010% (Data available from 1/1/2016 forward) CANC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CANC shares? During the previous two years, the following institutional investors and hedge funds held shares of Tema Oncology ETF shares: Thrivent Financial for Lutherans ($11.35M), Jane Street Group LLC ($1.26M).Learn more on CANC's institutional investors. Which institutional investors have been buying Tema Oncology ETF stock? The following institutional investors have purchased Tema Oncology ETF stock in the last 24 months: Thrivent Financial for Lutherans ($399.51K). How much institutional buying is happening at Tema Oncology ETF? Institutional investors have bought a total of 399,509 shares in the last 24 months. This purchase volume represents approximately $10.89M in transactions. Which Tema Oncology ETF major shareholders have been selling company stock? The following institutional investors have sold Tema Oncology ETF stock in the last 24 months: Jane Street Group LLC ($98.88K). How much institutional selling is happening at Tema Oncology ETF? Institutional investors have sold a total of 98,880 shares in the last 24 months. This volume of shares sold represents approximately $2.81M in transactions. Related Companies FDFF Major Shareholders SARK Major Shareholders OZEM Major Shareholders UFO Major Shareholders SPRX Major Shareholders FDNI Major Shareholders DEMZ Major Shareholders FMED Major Shareholders BITS Major Shareholders FDCF Major Shareholders This page (NASDAQ:CANC) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Oncology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Oncology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
